Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Non-invasive Prenatal Testing (NIPT) Market worth $14.1 billion by 2029 driven by Rising Tech Innovations | MarketsandMarkets™


News provided by

MarketsandMarkets

02 Sep, 2024, 14:30 GMT

Share this article

Share toX

Share this article

Share toX

DELRAY BEACH, Fla., Sept. 2, 2024 /PRNewswire/ -- The global Non-invasive Prenatal Testing (NIPT) Market is valued at an estimated USD 7.2 billion in 2024 and is projected to reach USD 14.1 billion by 2029 at a CAGR of 14.5% during the forecast period. The global non-invasive prenatal testing (NIPT) market is driven by rising investments and support from governments and private sectors, along with a growing preference for non-invasive methods over traditional invasive techniques due to the safety they offer for both mother and fetus. Technological advancements, particularly in next-generation sequencing, have improved the precision of NIPT, allowing for early detection of chromosomal abnormalities like trisomy 21. However, the market faces challenges such as high costs and a lack of skilled professionals, especially in low-income regions. Despite these barriers, increasing awareness and continued innovation are expected to drive market growth, with North America leading due to its robust healthcare infrastructure. Key players in the market include Illumina, Natera, Eurofins Scientific, and F. Hoffmann-La Roche, among others.

This image opens in the lightbox
MarketsandMarkets

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690

Browse in-depth TOC on "Non-invasive Prenatal Testing (NIPT) Market"

506 - Tables
63 - Figures
370 - Pages

Illumina, Inc.: Pioneering Genetic Analysis Solutions

Illumina, Inc. (US) leads the molecular diagnostics space with integrated systems for analyzing genetic variation and biological functions. The company offers a comprehensive range of products, including integrated systems, consumables, and analysis tools, simplifying genetic research. Its non-invasive prenatal testing products are part of its core Illyming business. Additionally, Illumina provides advanced software and cloud-based informatics platforms for sequencing and array-based systems, catering to genomic research centers, pharmaceutical companies, hospitals, and academic institutions. Illumina's global footprint extends across North America, Europe, Latin America, the Middle East, Africa, and Asia Pacific. Key subsidiaries include BlueGnome, Epic Sciences, and Verinata Health. In 2024, the company launched DRAGEN v4.3, its next-generation sequencing software, and in 2023, opened a new office in Bengaluru, India, to strengthen its APAC presence.

Thermo Fisher Scientific, Inc.: Expanding Global Diagnostics Reach

Thermo Fisher Scientific, Inc. (US) is a global leader in analytical tools, reagents, and laboratory equipment, serving diverse sectors such as pharmaceuticals, biotechnology, hospitals, and research institutions. The company operates across four main segments: Laboratory Products and Services, Life Sciences Solutions, Specialty Diagnostics, and Analytical Instruments. Its Life Sciences and Specialty Diagnostics segments offer sequencing reagents, PCR instruments, and software solutions. With a presence in over 150 countries, Thermo Fisher's global operations span North America, Europe, Latin America, and Asia. The company operates under five key brands, including Thermo Scientific and Invitrogen. In 2023, Thermo Fisher partnered with Pfizer to expand next-generation sequencing testing in over 30 countries across Latin America, Africa, the Middle East, and Asia.

F. Hoffmann-LA Roche AG: Advancing Diagnostics and Pharmaceuticals

F. Hoffmann-LA Roche AG (Switzerland) is a global pharmaceutical leader, with its Diagnostics division specializing in molecular diagnostics and sequencing solutions. Roche provides PCR products and genome sequencers for hospitals, research institutes, and clinical labs. With operations in over 100 countries and 29 manufacturing sites globally, Roche serves a wide network across the US, China, Germany, and more. The company's subsidiaries, including Chugai Pharmaceutical and Foundation Medicine, enhance its global reach. In 2021, Roche launched the AVENIO Edge System to automate next-generation sequencing sample preparation and acquired TIB Molbiol to strengthen its rapid diagnostic capabilities for emerging pathogens.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=145607690

Product Segment: Products Dominate the NIPT Market

The non-invasive prenatal testing (NIPT) market is segmented by product and service type into products and services. In 2023, the product segment held the largest share of the market. This growth is attributed to the rising demand for advanced, accurate, and early detection of fetal genetic conditions. Technological advancements, increased awareness among expectant parents, and the growing prevalence of chromosomal disorders contribute to this demand. The non-invasive nature of NIPT, which minimizes risk to both mother and fetus, further drives its adoption as a preferred option for prenatal screening, boosting product demand.

Method Segment: Biochemical Screening Tests See Significant Growth

The NIPT market is divided by method type into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests. In 2023, the biochemical screening tests segment held the third-largest market share. Its growth is driven by affordability, accessibility, and early detection capabilities, providing essential information about potential chromosomal abnormalities. Increased awareness and the demand for early, non-invasive prenatal screening, coupled with advancements in technology and a rise in chromosomal disorders, contribute to the expansion of this segment.

Application Segment: Trisomy Leads the NIPT Market

The NIPT market is segmented by application into trisomy, microdeletion syndrome, and other applications. In 2023, the trisomy segment accounted for the largest market share. This growth is driven by rising awareness of trisomy conditions like Down syndrome and the growing demand for early detection. The non-invasive nature of NIPT allows for safe, early identification of trisomy conditions during pregnancy, enabling timely medical interventions and informed decisions, which supports the expansion of this segment.

End User Segment: Diagnostic Laboratories Experience Rapid Growth

The NIPT market is segmented by end user into diagnostic laboratories, hospitals, and others. In 2023, the diagnostic laboratories segment experienced the fastest compound annual growth rate (CAGR). This growth is primarily attributed to strong connections with healthcare providers, which facilitate sample collection and quick results. The seamless testing process fosters trust among doctors and patients, driving the preference for diagnostic labs and accelerating the growth of this market segment.

Regional Insights: Europe Holds the Second-Largest Market Share

The NIPT market is divided by region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2023, Europe held the second-largest market share. This is driven by advancements in medical technology, a high prevalence of genetic disorders, and a strong healthcare infrastructure. Robust healthcare systems, increased awareness of prenatal screening, and favorable reimbursement policies further support the adoption of NIPT, contributing to the growth and accessibility of prenatal care in Europe.

For more information, inquire now! Inquire Now

Related Reports:

Single Cell Analysis Market

Digital PCR Market

Preimplantation Genetic Testing Market

NGS Sample Preparation Market

Next Generation Sequencing Market

Get access to the latest updates on Non Invasive Prenatal Testing Companies and Non Invasive Prenatal Testing Market Share

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

Modal title

Also from this source

ETFE & ECTFE Coatings Market worth $0.73 billion in 2030 - Exclusive Report by MarketsandMarkets™

ETFE & ECTFE Coatings Market worth $0.73 billion in 2030 - Exclusive Report by MarketsandMarkets™

The report "ETFE & ECTFE Coatings Market by Chemistry (ETFE, ECTFE), Form (Liquid, Powder), End-Use Industry (Semiconductor, Pharmaceuticals, Food &...

Breast Biopsy Devices Market worth US$3,261.7 million by 2030 with 6.5% CAGR | MarketsandMarkets™

Breast Biopsy Devices Market worth US$3,261.7 million by 2030 with 6.5% CAGR | MarketsandMarkets™

The global Breast Biopsy Devices Market, valued at US$2,255.0 million in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$2,384.1...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

Medical Equipment

Medical Equipment

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.